{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:47:50Z","timestamp":1790203670605,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H07222"],"award-info":[{"award-number":["17H07222"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04252"],"award-info":[{"award-number":["17H04252"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K19761"],"award-info":[{"award-number":["18K19761"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18dk0307077"],"award-info":[{"award-number":["JP18dk0307077"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Previous reports have shown that during chronic inflammation, the tryptophan (TRP)-kynurenine (KYN) pathway plays a pivotal role in the onset of depression. The aim of this study was to investigate the characteristics of the serum TRP-KYN pathway metabolite profile in high-risk subjects of major depressive disorder (HRMDD) defined by depression scores. The concentrations of TRP-KYN pathway metabolites {TRP, KYN, 3-hydroxyanthranilic acid (3HAA), 3-hydroxykynurenine (3HK), kynurenic acid (KYNA) and anthranilic acid (AA)} were assessed in serum from HRMDD, chronic pain disorder patients and healthy controls. In serum from HRMDD, elevated levels of AA and decreased levels of TRP were observed, but the levels of other metabolites were not changed. Furthermore, the change in the AA\n                    <jats:sub>2nd<\/jats:sub>\n                    \/AA\n                    <jats:sub>1st<\/jats:sub>\n                    ratio in subjects who progressed from a healthy state to a depressive state was correlated with an increase in the CES-D score. The level of IL-1 receptor antagonist (IL-1RA) was negatively correlated with that of AA. Interestingly, we confirmed AA as a possible biomarker for depression-related symptoms, since the metabolite profiles in the chronic pain disorder group and chronic unpredictable mild stress model mice were similar to those in the HRMDD. These results suggest that AA may be an effective marker for HRMDD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-58806-w","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T06:04:48Z","timestamp":1580969088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder"],"prefix":"10.1038","volume":"10","author":[{"given":"Masashi","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyo","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3833-4041","authenticated-orcid":false,"given":"Akihiro","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Matsunami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-6806","authenticated-orcid":false,"given":"Tomoya","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiji Sato","family":"(Boku)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tonoike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-4898","authenticated-orcid":false,"given":"Norio","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"58806_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong, M. L. & Licinio, J. Research and treatment approaches to depression. Nature Reviews Neuroscience 2, 343\u2013351, https:\/\/doi.org\/10.1038\/35072566 (2001).","journal-title":"Nature Reviews Neuroscience"},{"key":"58806_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2007.03.011","volume":"21","author":"A Steptoe","year":"2007","unstructured":"Steptoe, A., Hamer, M. & Chida, Y. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity 21, 901\u2013912, https:\/\/doi.org\/10.1016\/j.bbi.2007.03.011 (2007).","journal-title":"Brain, Behavior, and Immunity"},{"key":"58806_CR3","doi-asserted-by":"crossref","unstructured":"Leonard, B. E. In Modern Trends in Pharmacopsychiatry Vol. 27 53\u201371 (2010).","DOI":"10.1159\/000319504"},{"key":"58806_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes, M. P. et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115, 1249\u20131273, https:\/\/doi.org\/10.1093\/brain\/115.5.1249 (1992).","journal-title":"Brain"},{"key":"58806_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1471-4159.1978.tb07815.x","volume":"30","author":"EM G\u00e1l","year":"1978","unstructured":"G\u00e1l, E. M. & Sherman, A. D. Synthesis And Metabolism Of L\u2010Kynurenine In Rat Brain. Journal of Neurochemistry 30, 607\u2013613, https:\/\/doi.org\/10.1111\/j.1471-4159.1978.tb07815.x (1978).","journal-title":"Journal of Neurochemistry"},{"key":"58806_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-0028-1094391","volume":"6","author":"IP Lapin","year":"1973","unstructured":"Lapin, I. P. Kynurenines as probable participants of depression. Pharmakopsychiatrie und Neuropsychopharmakologie 6, 273\u2013279 (1973).","journal-title":"Pharmakopsychiatrie und Neuropsychopharmakologie"},{"key":"58806_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","volume":"34","author":"DH Munn","year":"2013","unstructured":"Munn, D. H. & Mellor, A. L. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends in Immunology 34, 137\u2013143, https:\/\/doi.org\/10.1016\/j.it.2012.10.001 (2013).","journal-title":"Trends in Immunology"},{"key":"58806_CR8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","volume":"281","author":"DH Munn","year":"1998","unstructured":"Munn, D. H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191\u20131193 (1998).","journal-title":"Science"},{"key":"58806_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","volume":"112","author":"H Fujigaki","year":"2017","unstructured":"Fujigaki, H., Yamamoto, Y. & Saito, K. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences. Neuropharmacology 112, 264\u2013274, https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.011 (2017).","journal-title":"Neuropharmacology"},{"key":"58806_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu, K. et al. Kynurenine pathway in depression: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews 90, 16\u201325, https:\/\/doi.org\/10.1016\/j.neubiorev.2018.03.023 (2018).","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"58806_CR11","unstructured":"Dantzer, R. In Current Topics in Behavioral Neurosciences Vol. 31 (2017)."},{"key":"58806_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbr.2015.04.017","volume":"288","author":"Y Xu","year":"2015","unstructured":"Xu, Y., Sheng, H., Tang, Z., Lu, J. & Ni, X. Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency. Behavioural Brain Research 288, 71\u201378, https:\/\/doi.org\/10.1016\/j.bbr.2015.04.017 (2015).","journal-title":"Behavioural Brain Research"},{"key":"58806_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor, J. C. et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular Psychiatry 14, 511\u2013522, https:\/\/doi.org\/10.1038\/sj.mp.4002148 (2009).","journal-title":"Molecular Psychiatry"},{"key":"58806_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.psyneuen.2018.11.001","volume":"101","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder. Psychoneuroendocrinology 101, 72\u201379, https:\/\/doi.org\/10.1016\/j.psyneuen.2018.11.001 (2019).","journal-title":"Psychoneuroendocrinology"},{"key":"58806_CR15","doi-asserted-by":"publisher","unstructured":"Murakami, Y. et al. Depressive symptoms as a side effect of Interferon-\u03b1 therapy induced by induction of indoleamine 2,3-dioxygenase 1. Scientific Reports 6, https:\/\/doi.org\/10.1038\/srep29920 (2016).","DOI":"10.1038\/srep29920"},{"key":"58806_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/IJTR.S4282","volume":"3","author":"LG Darlington","year":"2010","unstructured":"Darlington, L. G. et al. On the biological importance of the 3-hydroxyanthranilic acid: Anthranilic acid ratio. International Journal of Tryptophan Research 3, 51\u201359 (2010).","journal-title":"International Journal of Tryptophan Research"},{"key":"58806_CR17","unstructured":"Oxenkrug G, V. d. H. M., Roeser J, Summergrad P. Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia. Ann Psychiatry Ment Health. 4(2) (2016)."},{"key":"58806_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff, L. S. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement 1, 385\u2013401, https:\/\/doi.org\/10.1177\/014662167700100306 (1977).","journal-title":"Applied Psychological Measurement"},{"key":"58806_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/pr.113.008144","volume":"66","author":"AK Walker","year":"2014","unstructured":"Walker, A. K., Kavelaars, A., Heijnen, C. J. & Dantzer, R. Neuroinflammation and comorbidity of pain and depression. Pharmacological Reviews 66, 80\u2013101, https:\/\/doi.org\/10.1124\/pr.113.008144 (2014).","journal-title":"Pharmacological Reviews"},{"key":"58806_CR20","doi-asserted-by":"publisher","unstructured":"Doan, L., Manders, T. & Wang, J. Neuroplasticity underlying the comorbidity of pain and depression. Neural Plasticity 2015, https:\/\/doi.org\/10.1155\/2015\/504691 (2015).","DOI":"10.1155\/2015\/504691"},{"key":"58806_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbr.2014.04.042","volume":"276","author":"JX Li","year":"2015","unstructured":"Li, J. X. Pain and depression comorbidity: A preclinical perspective. Behavioural Brain Research 276, 92\u201398, https:\/\/doi.org\/10.1016\/j.bbr.2014.04.042 (2015).","journal-title":"Behavioural Brain Research"},{"key":"58806_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2174\/1389450111314050002","volume":"14","author":"G Oxenkrug","year":"2013","unstructured":"Oxenkrug, G. Serotonin - kynurenine hypothesis of depression: Historical overview and recent developments. Current Drug Targets 14, 514\u2013521, https:\/\/doi.org\/10.2174\/1389450111314050002 (2013).","journal-title":"Current Drug Targets"},{"key":"58806_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pnpbp.2012.10.006","volume":"48","author":"B Sperner-Unterweger","year":"2014","unstructured":"Sperner-Unterweger, B., Kohl, C. & Fuchs, D. Immune changes and neurotransmitters: Possible interactions in depression? Progress in Neuro-Psychopharmacology and Biological Psychiatry 48, 268\u2013276, https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.006 (2014).","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"58806_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/1871523011009030212","volume":"9","author":"MB Currier","year":"2010","unstructured":"Currier, M. B. & Nemeroff, C. B. Inflammation and mood disorders: Proinflammatory cytokines and the pathogenesis of depression. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry 9, 212\u2013220 (2010).","journal-title":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry"},{"key":"58806_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.neuroscience.2005.03.051","volume":"135","author":"S Hayley","year":"2005","unstructured":"Hayley, S., Poulter, M. O., Merali, Z. & Anisman, H. The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135, 659\u2013678, https:\/\/doi.org\/10.1016\/j.neuroscience.2005.03.051 (2005).","journal-title":"Neuroscience"},{"key":"58806_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","volume":"25","author":"R Yirmiya","year":"2011","unstructured":"Yirmiya, R. & Goshen, I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behavior, and Immunity 25, 181\u2013213, https:\/\/doi.org\/10.1016\/j.bbi.2010.10.015 (2011).","journal-title":"Brain, Behavior, and Immunity"},{"key":"58806_CR27","first-page":"664","volume":"10","author":"JW Koo","year":"2009","unstructured":"Koo, J. W. & Duman, R. S. Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Current Opinion in Investigational Drugs 10, 664\u2013671 (2009).","journal-title":"Current Opinion in Investigational Drugs"},{"key":"58806_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison, C. L., Capuron, L. & Miller, A. H. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology 27, 24\u201331, https:\/\/doi.org\/10.1016\/j.it.2005.11.006 (2006).","journal-title":"Trends in Immunology"},{"key":"58806_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bbi.2009.02.018","volume":"23","author":"L Brydon","year":"2009","unstructured":"Brydon, L., Walker, C., Wawrzyniak, A. J., Chart, H. & Steptoe, A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain, Behavior, and Immunity 23, 810\u2013816, https:\/\/doi.org\/10.1016\/j.bbi.2009.02.018 (2009).","journal-title":"Brain, Behavior, and Immunity"},{"key":"58806_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jpsychires.2012.12.001","volume":"47","author":"D Sasayama","year":"2013","unstructured":"Sasayama, D. et al. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. Journal of Psychiatric Research 47, 401\u2013406, https:\/\/doi.org\/10.1016\/j.jpsychires.2012.12.001 (2013).","journal-title":"Journal of Psychiatric Research"},{"key":"58806_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.psyneuen.2014.03.013","volume":"45","author":"J Quak","year":"2014","unstructured":"Quak, J. et al. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? Psychoneuroendocrinology 45, 202\u2013210, https:\/\/doi.org\/10.1016\/j.psyneuen.2014.03.013 (2014).","journal-title":"Psychoneuroendocrinology"},{"key":"58806_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"98","author":"AM Myint","year":"2007","unstructured":"Myint, A. M. et al. Kynurenine pathway in major depression: Evidence of impaired neuroprotection. Journal of Affective Disorders 98, 143\u2013151, https:\/\/doi.org\/10.1016\/j.jad.2006.07.013 (2007).","journal-title":"Journal of Affective Disorders"},{"key":"58806_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","volume":"50","author":"R Schwarcz","year":"2001","unstructured":"Schwarcz, R. et al. Increased cortical kynurenate content in schizophrenia. Biological Psychiatry 50, 521\u2013530, https:\/\/doi.org\/10.1016\/S0006-3223(01)01078-2 (2001).","journal-title":"Biological Psychiatry"},{"key":"58806_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/schbul\/sbq086","volume":"38","author":"KR Linderholm","year":"2012","unstructured":"Linderholm, K. R. et al. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophrenia Bulletin 38, 426\u2013432, https:\/\/doi.org\/10.1093\/schbul\/sbq086 (2012).","journal-title":"Schizophrenia Bulletin"},{"key":"58806_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/mp.2013.11","volume":"19","author":"C Lavebratt","year":"2014","unstructured":"Lavebratt, C. et al. The KMO allele encoding Arg 452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression. Molecular Psychiatry 19, 334\u2013341, https:\/\/doi.org\/10.1038\/mp.2013.11 (2014).","journal-title":"Molecular Psychiatry"},{"key":"58806_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint, A. M. Kynurenines: From the perspective of major psychiatric disorders. FEBS Journal 279, 1375\u20131385, https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08551.x (2012).","journal-title":"FEBS Journal"},{"key":"58806_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.06.004","volume":"97","author":"T Pawlowski","year":"2018","unstructured":"Pawlowski, T. et al. Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-\u03b1 2a treatment. Psychoneuroendocrinology 97, 1\u20137, https:\/\/doi.org\/10.1016\/j.psyneuen.2018.06.004 (2018).","journal-title":"Psychoneuroendocrinology"},{"key":"58806_CR38","doi-asserted-by":"publisher","unstructured":"Chatterjee, P. et al. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-\u03b2 load: A pilot study. Scientific Reports 8, https:\/\/doi.org\/10.1038\/s41598-018-25968-7 (2018).","DOI":"10.1038\/s41598-018-25968-7"},{"key":"58806_CR39","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87, 2095\u20132147 (1996).","journal-title":"Blood"},{"key":"58806_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.mp.4000586","volume":"4","author":"J Licinio","year":"1999","unstructured":"Licinio, J. & Wong, M. L. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Molecular Psychiatry 4, 317\u2013327, https:\/\/doi.org\/10.1038\/sj.mp.4000586 (1999).","journal-title":"Molecular Psychiatry"},{"key":"58806_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0006-8993(95)00930-O","volume":"695","author":"SF Maier","year":"1995","unstructured":"Maier, S. F. & Watkins, L. R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Research 695, 279\u2013282, https:\/\/doi.org\/10.1016\/0006-8993(95)00930-O (1995).","journal-title":"Brain Research"},{"key":"58806_CR42","first-page":"237","volume":"52","author":"M Kubera","year":"2000","unstructured":"Kubera, M. et al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: Comparison between the acute state and after remission. Polish Journal of Pharmacology 52, 237\u2013241 (2000).","journal-title":"Polish Journal of Pharmacology"},{"key":"58806_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/08964289909595741","volume":"25","author":"KH Schmeelk","year":"1999","unstructured":"Schmeelk, K. H., Granger, D. A., Susman, E. J. & Chrousos, G. P. Maternal depression and risk for postpartum complications: Role of prenatal corticotropin-releasing hormone and interleukin-1 receptor antagonist. Behavioral Medicine 25, 88\u201394, https:\/\/doi.org\/10.1080\/08964289909595741 (1999).","journal-title":"Behavioral Medicine"},{"key":"58806_CR44","unstructured":"Goldberg, D. P. The detection of psychiatric illness by questionnaire: A technique for the identification and assessment of non-psychotic psychiatric illness. Oxford, England: Oxford U. Press. (1972)."},{"key":"58806_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.1525-1497.1997.00076.x","volume":"12","author":"MA Whooley","year":"1997","unstructured":"Whooley, M. A., Avins, A. L., Miranda, J. & Browner, W. S. Case-finding instruments for depression: Two questions are as good as many. Journal of General Internal Medicine 12, 439\u2013445, https:\/\/doi.org\/10.1046\/j.1525-1497.1997.00076.x (1997).","journal-title":"Journal of General Internal Medicine"},{"key":"58806_CR46","unstructured":"Association, A. P. Diagnostic and Statistical Manual of Mental Disorders, 4th ed text Revision (DSM-IV-TR). Washington DC: Amer Psychiatric Pub (2000)."},{"key":"58806_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. Journal of neurology, neurosurgery, and psychiatry 23, 56\u201362, https:\/\/doi.org\/10.1136\/jnnp.23.1.56 (1960).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"58806_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bbr.2016.09.050","volume":"317","author":"T Tashiro","year":"2017","unstructured":"Tashiro, T. et al. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions. Behavioural Brain Research 317, 279\u2013285, https:\/\/doi.org\/10.1016\/j.bbr.2016.09.050 (2017).","journal-title":"Behavioural Brain Research"},{"key":"58806_CR49","doi-asserted-by":"publisher","unstructured":"Lu, Q. et al. Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression. Behavioural Brain Research 372, https:\/\/doi.org\/10.1016\/j.bbr.2019.112053 (2019).","DOI":"10.1016\/j.bbr.2019.112053"},{"key":"58806_CR50","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1523\/JNEUROSCI.6458-11.2012","volume":"32","author":"A Mouri","year":"2012","unstructured":"Mouri, A. et al. MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation. Journal of Neuroscience 32, 4562\u20134580, https:\/\/doi.org\/10.1523\/JNEUROSCI.6458-11.2012 (2012).","journal-title":"Journal of Neuroscience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41598-020-58806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41598-020-58806-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41598-020-58806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:30:54Z","timestamp":1684607454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58806-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["58806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58806-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1961"}}